Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001642247-16-000005

CEO bought 36,706 shares at an average $0.89 ($32,535)

From the SEC's structured data for this filing

Trades in this filing

LAVOY THOMAS C · CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2016-03-11 Purchase : show line 1 in the form +25,005 $0.88 $22,004 118,528 D
2016-03-11 Purchase : show line 2 in the form +11,701 $0.90 $10,531 130,229 D
Open-market purchases · 36,706 sh · avg $0.89 · $32,535
Loading xslF345X03/primary_doc.xml…